These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37326645)

  • 1. Relationship between COVID-19 and ICU-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter before-after study.
    Kreitmann L; Jermoumi S; Vasseur M; Chabani M; Nourry E; Richard JC; Wallet F; Garçon P; Kachmar S; Zerbib Y; Van Grunderbeeck N; Vinsonneau C; Duhamel A; Labreuche J; Nseir S
    Intensive Care Med; 2023 Jul; 49(7):796-807. PubMed ID: 37326645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study.
    Kreitmann L; Vasseur M; Jermoumi S; Perche J; Richard JC; Wallet F; Chabani M; Nourry E; Garçon P; Zerbib Y; Van Grunderbeeck N; Vinsonneau C; Preda C; Labreuche J; Nseir S
    Intensive Care Med; 2023 Feb; 49(2):154-165. PubMed ID: 36592202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before-after study.
    Ledoux G; Six S; Lawson R; Labreuche J; Blazejewski C; Wallet F; Duhamel A; Nseir S
    Clin Microbiol Infect; 2016 Oct; 22(10):888.e11-888.e18. PubMed ID: 27451941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
    Álvarez-Lerma F; Catalán-González M; Álvarez J; Sánchez-García M; Palomar-Martínez M; Fernández-Moreno I; Garnacho-Montero J; Barcenilla-Gaite F; García R; Aranaz-Andrés J; Lozano-García FJ; Ramírez-Galleymore P; Martínez-Alonso M
    Med Intensiva (Engl Ed); 2023 Apr; 47(4):193-202. PubMed ID: 36670011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study.
    Nseir S; Di Pompeo C; Diarra M; Brisson H; Tissier S; Boulo M; Durocher A
    Crit Care Med; 2007 May; 35(5):1318-23. PubMed ID: 17414081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
    Nseir S; Grailles G; Soury-Lavergne A; Minacori F; Alves I; Durocher A
    Clin Microbiol Infect; 2010 Jul; 16(7):902-8. PubMed ID: 19694760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review.
    Gaudet A; Kreitmann L; Nseir S
    Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study.
    Yoshida H; Motohashi T; De Bus L; De Waele J; Takaba A; Kuriyama A; Kobayashi A; Tanaka C; Hashi H; Hashimoto H; Nashiki H; Shibata M; Kanamoto M; Inoue M; Hashimoto S; Katayama S; Fujiwara S; Kameda S; Shindo S; Suzuki T; Komuro T; Kawagishi T; Kawano Y; Fujita Y; Kida Y; Hara Y; Fujitani S;
    Antimicrob Resist Infect Control; 2022 Sep; 11(1):119. PubMed ID: 36175948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19.
    Baiou A; Elbuzidi AA; Bakdach D; Zaqout A; Alarbi KM; Bintaher AA; Ali MMB; Elarabi AM; Ali GAM; Daghfal J; Almaslamani MA; Ibrahim ASS; Alkhal A; Omrani AS
    J Hosp Infect; 2021 Apr; 110():165-171. PubMed ID: 33561503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical outcomes over time of inpatients with healthcare-associated or community-acquired coronavirus disease 2019 (COVID-19): A multicenter, prospective cohort study.
    Grant RL; Sauser J; Atkinson A; D'Incau S; Buetti N; Zanella MC; Harbarth S; Marschall J; Catho G;
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):75-81. PubMed ID: 37529850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant
    Mihalov P; Hodosy J; Koščálová A; Čaprnda M; Kachlíková M; Jurenka J; Bendžala M; Sabaka P
    Can J Infect Dis Med Microbiol; 2023; 2023():4951273. PubMed ID: 37745269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study.
    Vacheron CH; Lepape A; Savey A; Machut A; Timsit JF; Vanhems P; Le QV; Egbeola J; Martin M; Maxime V; Pugliesi PS; Maucort-Boulch D; Friggeri A;
    Crit Care Med; 2022 Mar; 50(3):449-459. PubMed ID: 34637422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
    Russo A; Gavaruzzi F; Ceccarelli G; Borrazzo C; Oliva A; Alessandri F; Magnanimi E; Pugliese F; Venditti M
    Infection; 2022 Feb; 50(1):83-92. PubMed ID: 34176088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.